Shares of Legend Biotech Corp. (LEGN) are trading up over 7 percent in the pre-market trade after the company registered a narrow loss for the first quarter, below analysts' estimates, helped by an increase in revenue.
LEGN are currently up by 9.39 percent at $47.30 in the pre-market trade on the Nasdaq.
For the first quarter, the company registered loss of $59.793 million or $0.16 per share, compared with loss of $112.101 million or $0.34 per share, recorded for the same period last year.
On average, seven analysts, polled by Thomson Reuters had forecast the firm to post loss of $0.34 per share, for the quarter.
Revenue surged to $93.991 million from $36.336 million last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.